| Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) |
JP |
$83.888B |
33.10 |
| Zoetis Inc. (ZTS) |
US |
$71.853B |
27.10 |
| Takeda Pharmaceutical Co. (TAK) |
JP |
$44.737B |
9.90 |
| Daiichi Sankyo Co., Ltd. - Sponsored ADR (DSNKY) |
JP |
$43.224B |
26.34 |
| Sandoz Group AG Sponsored ADR (SDZNY) |
CH |
$20.442B |
0.00 |
| Merck KGaA (MKKGY) |
DE |
$18.230B |
16.33 |
| Astellas Pharma Inc. (ALPMY) |
JP |
$17.608B |
12.47 |
| Summit Therapeutics PLC (SMMT) |
US |
$16.312B |
0.00 |
| United Therapeutics Corporation (UTHR) |
US |
$16.121B |
15.86 |
| Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) |
JP |
$12.709B |
0.00 |
| Neurocrine Biosciences, Inc. (NBIX) |
US |
$12.033B |
36.68 |
| Orion OYJ Unsponsored ADR (ORINY) |
FI |
$7.681B |
21.59 |
| Madrigal Pharmaceuticals, Inc. (MDGL) |
US |
$7.333B |
0.00 |
| Corcept Therapeutics Incorporated (CORT) |
US |
$6.657B |
50.43 |
| Stevanato Group S.p.A. (STVN) |
IT |
$6.329B |
40.98 |
| Hikma Pharmaceuticals Plc (HKMPF) |
GB |
$6.245B |
0.00 |
| Ionis Pharmaceuticals, Inc. (IONS) |
US |
$5.138B |
0.00 |
| Grifols, S.A. (GRFS) |
ES |
$5.122B |
0.00 |
| Ono Pharmaceutical Co. (OPHLF) |
JP |
$4.650B |
9.52 |
| Recursion Pharmaceuticals, Inc. (RXRX) |
US |
$3.626B |
0.00 |
| Crinetics Pharmaceuticals, Inc. (CRNX) |
US |
$3.474B |
0.00 |
| Catalyst Pharmaceuticals, Inc. (CPRX) |
US |
$2.579B |
11.69 |
| AMNEAL PHARMACEUTICALS, INC. (AMRX) |
US |
$2.426B |
14.50 |
| Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) |
GB |
$2.193B |
0.00 |
| Hypermarcas (HYPMY) |
BR |
$2.154B |
0.00 |
| Soleno Therapeutics, Inc. (SLNO) |
US |
$1.989B |
0.00 |
| BioCryst Pharmaceuticals, Inc. (BCRX) |
US |
$1.908B |
0.00 |
| NewAmsterdam Pharma Company N.V. (NAMS) |
NL |
$1.716B |
0.00 |
| Evotec AG (EVO) |
DE |
$1.573B |
0.00 |
| Dyne Therapeutics, Inc. (DYN) |
US |
$1.426B |
0.00 |
| Guardian Pharmacy Services, Inc. (GRDN) |
US |
$1.239B |
0.00 |
| Ardelyx, Inc. (ARDX) |
US |
$1.198B |
0.00 |
| Indivior PLC (INDV) |
US |
$1.165B |
5.06 |
| Aurinia Pharmaceuticals Inc (AUPH) |
CA |
$1.135B |
0.00 |
| Xencor, Inc. (XNCR) |
US |
$1.102B |
0.00 |
| Ocular Therapeutix, Inc. (OCUL) |
US |
$1.101B |
0.00 |
| ARS Pharmaceuticals, Inc. (SPRY) |
US |
$1.092B |
0.00 |
| Enliven Therapeutics, Inc. (ELVN) |
US |
$1.065B |
0.00 |
| Harrow, Inc. (HROW) |
US |
$1.031B |
0.00 |
| Collegium Pharmaceutical, Inc. (COLL) |
US |
$0.939B |
5.13 |
| Bioventus Inc. (BVS) |
US |
$0.812B |
25.67 |
| Avadel Pharmaceuticals PLC. (AVDL) |
IE |
$0.810B |
0.00 |
| Cronos Group Inc. (CRON) |
CA |
$0.754B |
0.00 |
| Relay Therapeutics, Inc. (RLAY) |
US |
$0.656B |
0.00 |
| Verve Therapeutics, Inc. (VERV) |
US |
$0.616B |
0.00 |
| USANA Health Sciences, Inc. (USNA) |
US |
$0.606B |
11.23 |
| Xeris Biopharma Holdings, Inc. (XERS) |
US |
$0.559B |
0.00 |
| Elite Pharmaceuticals Inc. (ELTP) |
US |
$0.521B |
0.00 |
| OmniAb, Inc. (OABI) |
US |
$0.515B |
0.00 |
| KalVista Pharmaceuticals, Inc. (KALV) |
US |
$0.496B |
0.00 |
| Savara Inc. (SVRA) |
US |
$0.462B |
0.00 |
| Theravance Biopharma, Inc. (TBPH) |
KY |
$0.458B |
0.00 |
| Altimmune, Inc. (ALT) |
US |
$0.457B |
0.00 |
| ProKidney Corp. (PROK) |
US |
$0.437B |
0.00 |
| Siga Technologies Inc. (SIGA) |
US |
$0.422B |
4.92 |
| Zevra Therapeutics, Inc. (ZVRA) |
US |
$0.410B |
0.00 |
| Organogenesis (ORGO) |
US |
$0.404B |
0.00 |
| Aldeyra Therapeutics, Inc. (ALDX) |
US |
$0.398B |
0.00 |
| Akebia Therapeutics, Inc. (AKBA) |
US |
$0.393B |
0.00 |
| Oruka Therapeutics, Inc. (ORKA) |
US |
$0.386B |
0.00 |
| CytoDyn Inc. (CYDY) |
US |
$0.368B |
0.00 |
| Esperion Therapeutics, Inc. (ESPR) |
US |
$0.359B |
0.00 |
| Rigel Pharmaceuticals, Inc. (RIGL) |
US |
$0.354B |
143.50 |
| Tourmaline Bio, Inc. (TRML) |
US |
$0.313B |
0.00 |
| Ironwood Pharmaceuticals, Inc. (IRWD) |
US |
$0.290B |
0.00 |
| Aquestive Therapeutics, Inc. (AQST) |
US |
$0.274B |
0.00 |
| Heron Therapeutics, Inc. (HRTX) |
US |
$0.263B |
0.00 |
| Avita Medical Inc. (RCEL) |
US |
$0.256B |
0.00 |
| Nature's Sunshine Products, Inc. (NATR) |
US |
$0.252B |
14.98 |
| Korro Bio, Inc. (KRRO) |
US |
$0.246B |
0.00 |
| Innate Pharma SA (IPHYF) |
FR |
$0.243B |
0.00 |
| Amylyx Pharmaceuticals, Inc. (AMLX) |
US |
$0.226B |
0.00 |
| Profound Medical (PROF) |
CA |
$0.225B |
0.00 |
| 4D Molecular Therapeutics, Inc. (FDMT) |
US |
$0.215B |
0.00 |
| Inhibikase Therapeutics, Inc. (IKT) |
US |
$0.206B |
0.00 |
| Lyell Immunopharma, Inc. (LYEL) |
US |
$0.205B |
0.00 |
| Larimar Therapeutics, Inc. (LRMR) |
US |
$0.204B |
0.00 |
| MediWound Ltd. (MDWD) |
IL |
$0.191B |
0.00 |
| Nanobiotix S.A. Sponsored ADR (NBTX) |
FR |
$0.177B |
0.00 |
| Acrivon Therapeutics, Inc. (ACRV) |
US |
$0.172B |
0.00 |
| Nektar Therapeutics (NKTR) |
US |
$0.172B |
0.00 |
| Enanta Pharmaceuticals, Inc. (ENTA) |
US |
$0.171B |
0.00 |
| VAXART, INC. (VXRT) |
US |
$0.162B |
0.00 |
| Aclaris Therapeutics, Inc. (ACRS) |
US |
$0.160B |
0.00 |
| Silence Therapeutics PLC Sponsored ADR (SLN) |
GB |
$0.143B |
0.00 |
| Champions Oncology, Inc. (CSBR) |
US |
$0.141B |
0.00 |
| Inotiv, Inc. (NOTV) |
US |
$0.137B |
0.00 |
| Lexeo Therapeutics, Inc. (LXEO) |
US |
$0.129B |
0.00 |
| Procaps Group, S.A. (PROCF) |
LU |
$0.126B |
0.00 |
| Cassava Sciences, Inc. (SAVA) |
US |
$0.123B |
0.00 |
| electroCore, Inc. (ECOR) |
US |
$0.118B |
0.00 |
| Telomir Pharmaceuticals, Inc. (TELO) |
US |
$0.116B |
0.00 |
| Achieve Life Sciences, Inc. (ACHV) |
CA |
$0.109B |
0.00 |
| Journey Medical Corporation (DERM) |
US |
$0.108B |
0.00 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) |
US |
$0.100B |
0.00 |
| Cardiol Therapeutics Inc. (CRDL) |
CA |
$0.099B |
0.00 |
| Galectin Therapeutics Inc. (GALT) |
US |
$0.094B |
0.00 |
| Arch Biopartners Inc. (ACHFF) |
CA |
$0.089B |
0.00 |
| Metagenomi, Inc. (MGX) |
US |
$0.088B |
0.00 |
| Avalo Therapeutics, Inc. (AVTX) |
US |
$0.088B |
0.00 |
| Regulus Therapeutics Inc. (RGLS) |
US |
$0.086B |
0.00 |
| Nutriband Inc. (NTRB) |
US |
$0.083B |
0.00 |
| Protara Therapeutics, Inc. (TARA) |
US |
$0.077B |
0.00 |
| ESSA Pharma Inc. (EPIX) |
CA |
$0.076B |
0.00 |
| Pyxis Oncology, Inc. (PYXS) |
US |
$0.076B |
0.00 |
| Karyopharm Therapeutics Inc. (KPTI) |
US |
$0.076B |
0.00 |
| Cumberland Pharmaceuticals Inc. (CPIX) |
US |
$0.075B |
0.00 |
| PMV Pharmaceuticals, Inc. (PMVP) |
US |
$0.073B |
0.00 |
| FibroGen, Inc (FGEN) |
US |
$0.071B |
0.00 |
| Mural Oncology PLC (MURA) |
IE |
$0.069B |
0.00 |
| Fractyl Health, Inc. (GUTS) |
US |
$0.068B |
0.00 |
| Vivani Medical, Inc. (VANI) |
US |
$0.068B |
0.00 |
| Unicycive Therapeutics, Inc. (UNCY) |
US |
$0.064B |
0.00 |
| Century Therapeutics, Inc. (IPSC) |
US |
$0.062B |
0.00 |
| AleAnna Inc. (ANNA) |
US |
$0.062B |
0.00 |
| Context Therapeutics Inc. (CNTX) |
US |
$0.061B |
0.00 |
| Gain Therapeutics, Inc. (GANX) |
US |
$0.060B |
0.00 |
| OptiNose, Inc. (OPTN) |
US |
$0.058B |
0.00 |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) |
US |
$0.053B |
0.00 |
| Dominari Holdings Inc. (DOMH) |
US |
$0.052B |
0.00 |
| Iterum Therapeutics PLC (ITRM) |
IE |
$0.052B |
0.00 |
| Rafael Holdings, Inc. (RFL) |
US |
$0.050B |
0.00 |
| AlloVir, Inc. (ALVR) |
US |
$0.049B |
0.00 |
| Prelude Therapeutics Incorporated (PRLD) |
US |
$0.048B |
0.00 |
| SCYNEXIS, Inc. (SCYX) |
US |
$0.041B |
0.00 |
| VYNE Therapeutics Inc. (VYNE) |
US |
$0.040B |
0.00 |
| NRx Pharmaceuticals, Inc. (NRXP) |
US |
$0.039B |
0.00 |
| CASI Pharmaceuticals Inc. (CASI) |
CN |
$0.038B |
0.00 |
| Tempest Therapeutics, Inc. (TPST) |
US |
$0.038B |
0.00 |
| Surrozen, Inc. (SRZN) |
US |
$0.036B |
0.00 |
| Verrica Pharmaceuticals Inc. (VRCA) |
US |
$0.034B |
0.00 |
| PolyPid Ltd. (PYPD) |
IL |
$0.030B |
0.00 |
| Incannex Healthcare Inc. (IXHL) |
AU |
$0.029B |
0.00 |
| Jupiter Neurosciences, Inc. (JUNS) |
US |
$0.028B |
0.00 |
| BioVie Inc. (BIVI) |
US |
$0.027B |
0.00 |
| Natural Alternatives International, Inc. (NAII) |
US |
$0.025B |
0.00 |
| DURECT Corporation (DRRX) |
US |
$0.025B |
0.00 |
| Scienture Holdings, Inc. (SCNX) |
US |
$0.024B |
0.00 |
| Enlivex Therapeutics Ltd. (ENLV) |
IL |
$0.021B |
0.00 |
| Mannatech, Incorporated (MTEX) |
US |
$0.021B |
0.00 |
| GlycoMimetics, Inc. (GLYC) |
US |
$0.019B |
0.00 |
| Carisma Therapeutics Inc. (CARM) |
US |
$0.019B |
0.00 |
| Vivos Therapeutics, Inc. (VVOS) |
US |
$0.018B |
0.00 |
| Lipocine Inc. (LPCN) |
US |
$0.018B |
0.00 |
| MEI Pharma, Inc. (MEIP) |
US |
$0.017B |
0.00 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) |
US |
$0.017B |
0.00 |
| MARKER THERAPEUTICS, INC. (MRKR) |
US |
$0.017B |
0.00 |
| Traws Pharma, Inc. (TRAW) |
US |
$0.016B |
0.00 |
| Citius Pharmaceuticals, Inc. (CTXR) |
US |
$0.015B |
0.00 |
| Biomerica, Inc. (BMRA) |
US |
$0.015B |
0.00 |
| TherapeuticsMD, Inc. (TXMD) |
US |
$0.015B |
0.00 |
| Cosmos Health Inc. (COSM) |
US |
$0.014B |
0.00 |
| Lyra Therapeutics, Inc. (LYRA) |
US |
$0.013B |
0.00 |
| ProPhase Labs, Inc. (PRPH) |
US |
$0.013B |
0.00 |
| Minerva Neurosciences, Inc (NERV) |
US |
$0.013B |
0.00 |
| Nuvilex Inc. (PMCB) |
US |
$0.012B |
0.00 |
| BioLineRx Ltd. (BLRX) |
IL |
$0.012B |
0.00 |
| Phio Pharmaceuticals Corp. (PHIO) |
US |
$0.012B |
0.00 |
| Indaptus Therapeutics, Inc. (INDP) |
US |
$0.011B |
0.00 |
| Mangoceuticals, Inc. (MGRX) |
US |
$0.011B |
0.00 |
| Kiora Pharmaceuticals, Inc. (KPRX) |
US |
$0.010B |
0.00 |
| Klotho Neurosciences, Inc. (KLTO) |
US |
$0.010B |
0.00 |
| Talphera, Inc. (TLPH) |
US |
$0.010B |
0.00 |
| Jaguar Animal Health, Inc. (JAGX) |
US |
$0.010B |
0.00 |
| Relmada Therapeutics, Inc. (RLMD) |
US |
$0.009B |
0.00 |
| Ainos, Inc. (AIMD) |
US |
$0.009B |
0.00 |
| Addex Therapeutics Ltd. Sponsored ADR (ADXN) |
CH |
$0.008B |
0.00 |
| XTL Biopharmaceuticals Ltd. (XTLB) |
IL |
$0.008B |
0.00 |
| Plus Therapeutics, Inc. (PSTV) |
US |
$0.007B |
0.00 |
| NLS Pharmaceutics Ltd. (NLSP) |
CH |
$0.007B |
0.00 |
| Xenetic Biosciences, Inc. (XBIO) |
US |
$0.006B |
0.00 |
| Redhill Biopharma Ltd. (RDHL) |
IL |
$0.006B |
0.00 |
| Aptorum Group Limited (APM) |
GB |
$0.006B |
0.00 |
| TransCode Therapeutics Inc. (RNAZ) |
US |
$0.006B |
0.00 |
| Clearmind Medicine Inc. (CMND) |
CA |
$0.006B |
0.00 |
| CERo Therapeutics Holdings, Inc. (CERO) |
US |
$0.005B |
0.00 |
| SciSparc Ltd. (SPRC) |
IL |
$0.005B |
0.00 |
| Conduit Pharmaceuticals Inc. (CDT) |
US |
$0.004B |
0.00 |
| Sonoma Pharmaceuticals, Inc. (SNOA) |
US |
$0.004B |
0.00 |
| InMed Pharmaceuticals Inc. (INM) |
CA |
$0.004B |
0.00 |
| 60 Degrees Pharmaceuticals Inc. (SXTP) |
US |
$0.003B |
0.00 |
| XORTX Therapeutics Inc. (XRTX) |
CA |
$0.003B |
0.00 |
| Avenue Therapeutics, Inc. (ATXI) |
US |
$0.003B |
0.07 |
| Alaunos Therapeutics, Inc. (TCRT) |
US |
$0.003B |
0.00 |
| Qualigen Therapeutics, Inc. (QLGN) |
US |
$0.003B |
0.00 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
US |
$0.003B |
0.00 |
| SHINECO (SISI) |
CN |
$0.002B |
0.00 |
| Salarius Pharmaceuticals, Inc. (SLRX) |
US |
$0.002B |
0.00 |
| Galmed Pharmaceuticals Ltd. (GLMD) |
IL |
$0.002B |
0.00 |
| Heatwurx Inc. (PCSA) |
US |
$0.002B |
0.00 |
| Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) |
US |
$0.002B |
0.00 |
| Petros Pharmaceuticals, Inc. (PTPI) |
US |
$0.001B |
0.00 |
| China SXT Pharmaceuticals, Inc. (SXTC) |
CN |
$0.001B |
0.00 |
| TNF Pharmaceuticals, Inc. (TNFA) |
US |
$0.001B |
0.00 |
| Aditxt Inc. (ADTX) |
US |
$0.001B |
0.00 |
| PainReform Ltd. (PRFX) |
IL |
$0.000B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
CN |
$0.000B |
0.00 |
| 4D pharma PLC Sponsored ADR (LBPS) |
GB |
$0.000B |
0.00 |
| Patheon N.V. (PTHN) |
NL |
$0.000B |
0.00 |
| RVL Pharmaceuticals PLC (RVLP) |
US |
$0.000B |
0.00 |
